{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:17:42Z","timestamp":1789611462902,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12010-023-04606-7","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T07:02:09Z","timestamp":1688540529000},"page":"1386-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["B7-H3 Regulates Glucose Metabolism in Neuroblastom via Stat3\/c-Met Pathway"],"prefix":"10.1007","volume":"196","author":[{"given":"Xiaomin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"4606_CR1","doi-asserted-by":"crossref","unstructured":"Zafar, A., Wang, W., Liu, G., Wang, X., Xian, W., McKeon, F., Foster, J., & Zhou, J. (2021). Molecular targeting therapies for neuroblastoma: Progress and challenges. 41, 961\u20131021.","DOI":"10.1002\/med.21750"},{"key":"4606_CR2","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007). Neuroblastoma. Lancet (London England), 369, 2106\u20132120.","journal-title":"Lancet (London England)"},{"key":"4606_CR3","doi-asserted-by":"crossref","unstructured":"Jubierre, L., Jim\u00e9nez, C., Rovira, E., Soriano, A., S\u00e1bado, C., Gros, L., Llort, A., Hladun, R., Roma, J., Toledo, J. S., Gallego, S., & Segura, M. F. (2018). Targeting of epigenetic regulators in neuroblastoma. 50, 1\u201312.","DOI":"10.1038\/s12276-018-0077-2"},{"key":"4606_CR4","doi-asserted-by":"crossref","unstructured":"Hayes, L., Basta, N., Muirhead, C. R., Pole, J. D., Gibson, P., Monte, B. D., Irwin, M. S., Greenberg, M., Tweddle, D. A., & Mcnally, R. (2022). Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada. Environmental Health, 21, 30.","DOI":"10.1186\/s12940-022-00846-y"},{"key":"4606_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","volume":"66","author":"CU Louis","year":"2015","unstructured":"Louis, C. U., & Shohet, J. M. (2015). Neuroblastoma: Molecular pathogenesis and therapy. Annual review of medicine, 66, 49\u201363.","journal-title":"Annual review of medicine"},{"key":"4606_CR6","doi-asserted-by":"crossref","unstructured":"Rovigatti, U. (2020). The glycosphingolipid GD2 as an effective but enigmatic target of passive immunotherapy in children with aggressive neuroblastoma (HR-NBL). Cancer Letters, 503, 220\u2013230.","DOI":"10.1016\/j.canlet.2020.11.044"},{"key":"4606_CR7","doi-asserted-by":"crossref","unstructured":"Kontos, F., & Michelakos, T. (2021). B7-H3: An attractive target for antibody-based Immunotherapy. 27, 1227\u20131235.","DOI":"10.1158\/1078-0432.CCR-20-2584"},{"key":"4606_CR8","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.2174\/0929867326666190517115515","volume":"27","author":"K Flem-Karlsen","year":"2020","unstructured":"Flem-Karlsen, K., Fodstad, \u00d8., & Nunes-Xavier, C. E. (2020). B7-H3 Immune checkpoint protein in Human Cancer. Current medicinal chemistry, 27, 4062\u20134086.","journal-title":"Current medicinal chemistry"},{"key":"4606_CR9","doi-asserted-by":"publisher","first-page":"108153","DOI":"10.1016\/j.intimp.2021.108153","volume":"101","author":"R Feng","year":"2021","unstructured":"Feng, R., Chen, Y., Liu, Y., Zhou, Q., & Zhang, W. (2021). The role of B7-H3 in tumors and its potential in clinical application. International immunopharmacology, 101, 108153.","journal-title":"International immunopharmacology"},{"key":"4606_CR10","doi-asserted-by":"crossref","unstructured":"Dondero, A., Morini, M., Cangelosi, D., Mazzocco, K., Serra, M., Spaggiari, G. M., Rotta, G., Tondo, A., Locatelli, F., Castellano, A., Scuderi, F., Sementa, A. R., Eva, A., Conte, M., Garaventa, A., Bottino, C., & Castriconi, R. (2021). Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic\/therapeutic target in GD2neg\/low neuroblastoma variants. Journal for Immunotherapy of Cancer, 9, e002293.","DOI":"10.1136\/jitc-2020-002293"},{"key":"4606_CR11","doi-asserted-by":"publisher","first-page":"153595","DOI":"10.1016\/j.prp.2021.153595","volume":"226","author":"Y Peng","year":"2021","unstructured":"Peng, Y., Yang, H., & Li, S. (2021). The role of glycometabolic plasticity in cancer. Pathology research and practice, 226, 153595.","journal-title":"Pathology research and practice"},{"key":"4606_CR12","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.7150\/jca.29838","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z., Liu, J., Que, L., & Tang, X. (2019). The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K\/Akt\/mTOR pathway. Journal of Cancer, 10, 5770\u20135784.","journal-title":"Journal of Cancer"},{"key":"4606_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","volume":"2","author":"AI Chapoval","year":"2001","unstructured":"Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., & Chen, L. (2001). B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nature immunology, 2, 269\u2013274.","journal-title":"Nature immunology"},{"key":"4606_CR14","doi-asserted-by":"crossref","unstructured":"Liu, C., Zhang, G., Xiang, K., Kim, Y., Lavoie, R. R., Lucien, F., & Wen, T. (2022). Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy. 71, 1549\u20131567.","DOI":"10.1007\/s00262-021-03097-x"},{"key":"4606_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.7150\/ijbs.41105","volume":"16","author":"S Yang","year":"2020","unstructured":"Yang, S., Wei, W., & Zhao, Q. (2020). B7-H3, a checkpoint molecule, as a target for cancer immunotherapy. International journal of biological sciences, 16, 1767\u20131773.","journal-title":"International journal of biological sciences"},{"key":"4606_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccell.2019.01.002","volume":"35","author":"H Du","year":"2019","unstructured":"Du, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, B., Michaud, D., Greene, K., Herrera, S. G., Xu, Y., Sun, C., Chen, Y., Ma, X., Ferrone, C. R., Pylayeva-Gupta, Y., Yeh, J. J., Liu, R., Savoldo, B., Ferrone, S., & Dotti, G. (2019). Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric Antigen receptor T cells. Cancer cell, 35, 221\u2013237e228.","journal-title":"Cancer cell"},{"key":"4606_CR17","doi-asserted-by":"crossref","unstructured":"Michelakos, T., Kontos, F., Barakat, O., Maggs, L., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2021). B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert opinion on biological therapy 21, 587\u2013602.","DOI":"10.1080\/14712598.2021.1862791"},{"key":"4606_CR18","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-15-2428","volume":"22","author":"E Picarda","year":"2016","unstructured":"Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016). Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research, 22, 3425\u20133431.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"4606_CR19","doi-asserted-by":"publisher","first-page":"71725","DOI":"10.18632\/oncotarget.17847","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y., Yang, X., Wu, Y., Zhao, K., Ye, Z., Zhu, J., Xu, X., Zhao, X., & Xing, C. (2017). B7-H3 promotes gastric cancer cell migration and invasion. Oncotarget, 8, 71725\u201371735.","journal-title":"Oncotarget"},{"key":"4606_CR20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.7150\/jca.17759","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y., Guo, G., Song, J., Cai, Z., Yang, J., Chen, Z., Wang, Y., Huang, Y., & Gao, Q. (2017). B7-H3 promotes the Migration and Invasion of human bladder Cancer cells via the PI3K\/Akt\/STAT3 signaling pathway. Journal of Cancer, 8, 816\u2013824.","journal-title":"Journal of Cancer"},{"key":"4606_CR21","doi-asserted-by":"crossref","unstructured":"Kendsersky, N.M., Lindsay, J., Kolb, E.A., Smith, M.A., Teicher, B.A., Erickson, S.W., Earley, E.J., Mosse, Y.P., Martinez, D., Pogoriler, J., Krytska, K., Patel, K., Groff, D., Tsang, M., Ghilu, S., Wang, Y., Seaman, S., Feng, Y., Croix, B.S., Gorlick, R., Kurmasheva, R., Houghton, P.J., & Maris, J.M. (2021). The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models. Clinical Cancer Research, 27, 2938\u20132946.","DOI":"10.1158\/1078-0432.CCR-20-4221"},{"key":"4606_CR22","doi-asserted-by":"crossref","unstructured":"Sun, X., & Zhao, P. (2021). Ginsenoside Rh2 Inhibits Glycolysis through the STAT3\/c-MYC Axis in Non-Small-Cell Lung Cancer. 2021, 9715154.","DOI":"10.1155\/2021\/9715154"},{"key":"4606_CR23","doi-asserted-by":"crossref","unstructured":"Huo, N., Cong, R., & Sun, Z. J. (2021). STAT3\/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis. 12, 799.","DOI":"10.1038\/s41419-021-04081-0"},{"key":"4606_CR24","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.18632\/oncotarget.3420","volume":"6","author":"K Chang","year":"2015","unstructured":"Chang, K., Karnad, A., Zhao, S., & Freeman, J. W. (2015). Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets. Oncotarget, 6, 3507\u20133518.","journal-title":"Oncotarget"},{"key":"4606_CR25","doi-asserted-by":"crossref","unstructured":"Fu, R., Jiang, S., Li, J., Chen, H., & Zhang, X. (2020). Activation of the HGF\/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression. Medical oncology (Northwood, London, England) 37, 24.","DOI":"10.1007\/s12032-020-01350-4"},{"key":"4606_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/13543784.2018.1462336","volume":"27","author":"G Pasquini","year":"2018","unstructured":"Pasquini, G., & Giaccone, G. (2018). C-MET inhibitors for advanced non-small cell lung cancer. Expert opinion on investigational drugs, 27, 363\u2013375.","journal-title":"Expert opinion on investigational drugs"},{"issue":"1","key":"4606_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41388-018-0407-9","volume":"38","author":"Z Liu","year":"2019","unstructured":"Liu, Z., Zhang, W., Phillips, J. B., Arora, R., McClellan, S., Li, J., Kim, J. H., Sobol, R. W., et al. (2019). Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene, 38(1), 88\u2013102.","journal-title":"Oncogene"},{"issue":"23","key":"4606_CR28","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.7150\/jca.29838","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z., Liu, J., Que, L., & Tang, X. (2019). The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K\/Akt\/mTOR pathway. Journal Of Cancer, 10(23), 5770\u20135784.","journal-title":"Journal Of Cancer"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04606-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T11:06:42Z","timestamp":1708340802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04606-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["4606"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04606-7","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"19 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Children\u2019s Hospital of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"No animals were used for studies that are the basis of this research. All human procedures followed were in accordance with the guidelines of Helsinki Declaration of 1975.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Signed informed consent was provided.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The author declares no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Decl2aration of Interest"}}]}}